Full Text View
Tabular View
Study Results
Related Studies
Rituxan in Churg Strauss Syndrome With Renal Involvement
This study has been terminated.
( Company providing study drug terminated study due to lack of funds )
Study NCT00424749   Information provided by Mayo Clinic

First Received on January 19, 2007.   Last Updated on November 3, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Churg-Strauss Syndrome
More general conditions related to this trial
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Autoimmune Diseases
Cardiovascular Diseases
Granuloma
Immune System Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Systemic Vasculitis
Vascular Diseases
Vasculitis
Interventions listed in this trial
Rituximab
Prednisone
Additional drug interventions recognized in this trial
Antibodies, Antineutrophil Cytoplasmic
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Fernando Fervenza
Genentech
Biogen Idec
National Center for Research Resources (NCRR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services